Cargando…

Editorial Expression of Concern: birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Detalles Bibliográficos
Autores principales: La, V., Fujikawa, R., Janzen, D. M., Nunez, M., Bainvoll, L., Hwang, L., Faull, K., Lawson, G., Memarzadeh, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070543/
https://www.ncbi.nlm.nih.gov/pubmed/30083616
http://dx.doi.org/10.1038/s41698-018-0062-1
_version_ 1783343686944292864
author La, V.
Fujikawa, R.
Janzen, D. M.
Nunez, M.
Bainvoll, L.
Hwang, L.
Faull, K.
Lawson, G.
Memarzadeh, S.
author_facet La, V.
Fujikawa, R.
Janzen, D. M.
Nunez, M.
Bainvoll, L.
Hwang, L.
Faull, K.
Lawson, G.
Memarzadeh, S.
author_sort La, V.
collection PubMed
description
format Online
Article
Text
id pubmed-6070543
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-60705432018-08-06 Editorial Expression of Concern: birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy La, V. Fujikawa, R. Janzen, D. M. Nunez, M. Bainvoll, L. Hwang, L. Faull, K. Lawson, G. Memarzadeh, S. NPJ Precis Oncol Addendum Nature Publishing Group UK 2018-08-01 /pmc/articles/PMC6070543/ /pubmed/30083616 http://dx.doi.org/10.1038/s41698-018-0062-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Addendum
La, V.
Fujikawa, R.
Janzen, D. M.
Nunez, M.
Bainvoll, L.
Hwang, L.
Faull, K.
Lawson, G.
Memarzadeh, S.
Editorial Expression of Concern: birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
title Editorial Expression of Concern: birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
title_full Editorial Expression of Concern: birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
title_fullStr Editorial Expression of Concern: birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
title_full_unstemmed Editorial Expression of Concern: birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
title_short Editorial Expression of Concern: birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
title_sort editorial expression of concern: birinapant sensitizes platinum-resistant carcinomas with high levels of ciap to carboplatin therapy
topic Addendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070543/
https://www.ncbi.nlm.nih.gov/pubmed/30083616
http://dx.doi.org/10.1038/s41698-018-0062-1
work_keys_str_mv AT lav editorialexpressionofconcernbirinapantsensitizesplatinumresistantcarcinomaswithhighlevelsofciaptocarboplatintherapy
AT fujikawar editorialexpressionofconcernbirinapantsensitizesplatinumresistantcarcinomaswithhighlevelsofciaptocarboplatintherapy
AT janzendm editorialexpressionofconcernbirinapantsensitizesplatinumresistantcarcinomaswithhighlevelsofciaptocarboplatintherapy
AT nunezm editorialexpressionofconcernbirinapantsensitizesplatinumresistantcarcinomaswithhighlevelsofciaptocarboplatintherapy
AT bainvolll editorialexpressionofconcernbirinapantsensitizesplatinumresistantcarcinomaswithhighlevelsofciaptocarboplatintherapy
AT hwangl editorialexpressionofconcernbirinapantsensitizesplatinumresistantcarcinomaswithhighlevelsofciaptocarboplatintherapy
AT faullk editorialexpressionofconcernbirinapantsensitizesplatinumresistantcarcinomaswithhighlevelsofciaptocarboplatintherapy
AT lawsong editorialexpressionofconcernbirinapantsensitizesplatinumresistantcarcinomaswithhighlevelsofciaptocarboplatintherapy
AT memarzadehs editorialexpressionofconcernbirinapantsensitizesplatinumresistantcarcinomaswithhighlevelsofciaptocarboplatintherapy